ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AP51 | B | Ledipasvir - 90mg, Sofosbuvir - 400mg | 10057/945 | 20519/1 | HARVONI | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Gilead Sciences Ireland UC | Ireland | 973,113,199 L.L | 2.44 | E2 | Gilead Sciences Ireland UC | Ireland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AP51 | B | Ledipasvir - 90mg, Sofosbuvir - 400mg | 10057 | 20519/1 | HARVONI | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Gilead Sciences Ireland UC | Ireland | 15,961,426 L.L | 2.44 | E2 | Gilead Sciences Ireland UC | Ireland | 2/5/2024 |